Legence financials
$53.70+0.54%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 |
|---|---|---|---|---|
| Revenue | $1.26B | $1.04B | $737.6M | $708.0M |
| Gross profit | $220.2M | $186.2M | $147.5M | $148.1M |
| Gross margin | 17.4% | 17.9% | 20.0% | 20.9% |
| Operating income | -$6.8M | $21.8M | $746.0K | $37.2M |
| Net income | -$27.8M | $16.1M | -$32.7M | -$576.0K |
| Net margin | −2.2% | 1.6% | −4.4% | −0.1% |
| Diluted EPS | $-0.37 | $0.13 | $-32721.00 | $-576.00 |
| EBITDA | $78.9M | $75.5M | $36.6M | $38.0M |
| Operating cash flow | $74.4M | $120.1M | $94.7M | — |
| Free cash flow | $50.3M | $102.3M | $81.5M | — |
| Diluted shares | 76.0M | 108.4M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|
| Cash & equivalents | $292.0M | $244.6M | $230.2M | $176.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.03B | $1.03B | $829.1M | $828.9M |
| Total assets | $3.74B | $3.48B | $2.68B | $2.60B |
| Total liabilities | $2.76B | $2.53B | $1.89B | $1.77B |
| Shareholders' equity | $977.5M | $951.0M | $788.8M | $827.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology